Lifespan Vision Ventures

Develops durable protein therapeutics via gene therapy for chronic diseases

Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform

Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases